Literature DB >> 23953342

Review of the American College of Chest Physicians 2012 Guidelines for Anticoagulation Therapy and Prevention of Thrombosis.

Rajiv K Pruthi1.   

Abstract

The eighth edition (AT8) of the American College of Chest Physicians (ACCP) Antithrombotic Therapy and Prevention of Thrombosis Guideline, published in June 2008, was a comprehensive presentation of primary studies and detailed discussions of rationale for recommendations. This resulted in an approximately 900-page Chest Supplement publication. Updating the guidelines in a succinct fashion posed a formidable challenge for the ninth edition (AT9), published in February 2012. The strategy adopted for AT9 was to publish an Executive Summary of the recommendations in a 50-page document in the Chest supplement highlighting the changes, with online publication of the full version. Major innovative changes include a recognition of the value of estimating the risk reductions in symptomatic, as opposed to asymptomatic (venographically), detected venous thrombosis, using nonconflicted methodologists as topic editors, new insights into evidence, and increasing emphasis on what is known about patients' values and preferences that have served to improve this edition of the guidelines. This review provides a summary of the updates of the guidelines for anticoagulation therapy and prevention of thrombosis. The AT9 recommendations are presented with, if included, the AT8 recommendations in parenthesis for comparison purposes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23953342     DOI: 10.1053/j.seminhematol.2013.06.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  5 in total

1.  The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study.

Authors:  Tomasz Olesiński; Anna Fijałkowska; Andrzej Rutkowski
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

2.  Anticoagulant therapy with fondaparinux in a liver transplant patient with thrombosis and liver fibrosis: a case report.

Authors:  Arturo Cafolla; Giuseppe Gentile
Journal:  Clin Case Rep       Date:  2017-02-09

3.  Does anticoagulation needed for distally located incidental pulmonary thromboembolism in patients with active cancer?

Authors:  Haseong Chang; Min Sun Kim; Su Yeon Lee; Sun Hye Shin; Hye Yun Park; Sung-A Chang; Taek Kyu Park; Duk-Kyung Kim; Eun Kyoung Kim
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

4.  Differential clinical manifestations and clinical outcome of cancer-related pulmonary embolism.

Authors:  Min Sun Kim; Haseong Chang; Su Yeon Lee; Sun Hye Shin; HyeYun Park; Sung-A Chang; Taek Kyu Park; Duk-Kyung Kim; Eun Kyoung Kim
Journal:  Korean J Intern Med       Date:  2019-08-09       Impact factor: 2.884

5.  Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients.

Authors:  Long Bai; Xiao-Hong Yang; Ya-Qing Zhou; Xiao-Ran Cui; Ling-Zhi Fu; Ji-Dong Zhang
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.